Matthew M. Walsh - 04 May 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Financial Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Matthew M. Walsh
Issuer symbol
OGN
Transactions as of
04 May 2024
Net transactions value
-$80,264
Form type
4
Filing time
07 May 2024, 16:05:02 UTC
Previous filing
03 Apr 2024
Next filing
23 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +8,310 +9.9% $0.000000 92,419 04 May 2024 Direct
transaction OGN Common Stock Tax liability $80,264 -4,093 -4.4% $19.61 88,326 04 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -8,310 -100% $0.000000* 0 04 May 2024 Common Stock 8,310 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2 On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested.